A ngiotensin II has been implicated in the pathobiology of atherosclerosis and in the arterial response to injury and restenosis via mechanisms that include vascular hypertrophy, extracellular matrix production, and cytokine induction. Although the angiotensin-converting enzyme (ACE) is only one of several enzymes that can generate angiotensin II, 1 the enzyme has been allocated a central role in cardiovascular disease development, mainly on the basis of the positive effects observed in response to ACE inhibitor therapy and experimental work involving protein downregulation. 2 Certainly, ACE levels seem to correlate with disease development, and ACE protein has been detected in atherosclerotic human coronary 3, 4 and carotid lesions. 5 Relatively little is known about the signals that regulate ACE expression in vascular cells, but the exposure of vascular smooth muscle cells to fluid shear stress 6 or pulsatile pressure 7 is reported to increase expression of the enzyme. Although an identical phenomenon was initially reported in endothelial cells, 6 several other studies reported exactly the opposite, that is, that arterial levels of shear stress attenuate ACE promoter activity and decrease the expression of ACE mRNA in endothelial cells. [8] [9] [10] How can fluid shear stress regulate ACE expression? The first hypothesis was that the effects could be attributed to increased transcription as the genes for human, rat, and rabbit ACE all contain a number of shear stress-responsive elements in their promoter regions. These were however found to be inactive, and responsiveness to flow was then attributed to a combination of Barbie and GAGA response elements. 9 The transcription factor Krüppel-like factor 2 (KLF2) has also been linked to ACE expression because overexpression of the transcription factor decreases endothelial cell ACE expression. 10 Given that KLF2 is activated by shear stress to regulate the expression of proteins, such as the endothelial nitric oxide (NO) synthase, 10 it initially seemed that KLF2 activation could directly explain the shear stress-induced downregulation of ACE. This was a particularly attractive hypothesis because ACE has been reported to be a target of the miR-143/145 gene cluster in vascular smooth muscle cells, 11 and fluid shear stress was recently reported to increase the expression of miR-143/145 by a KLF2-dependent mechanism. 12 However, small interfering RNA (siRNA) directed against KLF2 failed to prevent the shear stress-induced downregulation of ACE RNA levels, 10 indicating that the mechanisms must be distinct. Recently, we reported that ACE levels in monocytes can be regulated by the AMP-activated protein kinase (AMPK). 13 Because this kinase is rapidly phosphorylated and thereby activated in endothelial cells exposed to shear stress, 14 we set out to determine whether or not the AMPK is involved in the shear stress-induced downregulation of ACE expression and whether a link exists to miR-143/145.
Methods
Detailed methods can be found in the Online Data Supplement.
Cell Culture
Human umbilical vein endothelial cells were isolated and cultured as described previously. 15 Human coronary artery endothelial cells were obtained from CellSystems Biotechnologie Vertrieb GmbH (Troisdorf, Germany), and human aortic endothelial cells were obtained from Lonza (Basel, Switzerland). Confluent cultures of endothelial cells were washed twice in culture medium containing 2% fetal calf serum and were either maintained under static conditions or exposed to shear stress (12 dyn/cm 2 ) in a temperature-controlled cone-plate viscosimeter, as described. 16 
Animals
Genetically modified mice lacking either the AMPKα1 or the AMPKα2 subunits, their respective wild-type littermates, 17 and floxed AMPKα2 mice were kindly provided by Benoit Viollet (INSERM, U1016, Paris, France) and bred at the Goethe University Hospital animal facility. Floxed AMPKα2 mice were crossed with animals expressing the Cre-deleter under the control of the VE-cadherin promoter to generate mice lacking the α2 subunit specifically in endothelial cells (AMPKα2 ΔEC ). Mice in which the miR-143/145-coding genomic region was replaced with a lacZ reporter (miR-LacZ) were generated as described, 11 and bred at the animal facility of the MaxPlanck-Institut für Herz-und Lungenforschung (Bad Nauheim, Germany).
Experimental diabetes mellitus was induced in C57BL/6 mice (Charles River, Sulzfeld, Germany) by a single intraperitoneal injection of streptozotocin (150 mg kg −1 body weight) 8 to 10 weeks before experiments. 18 Experiments conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23).
Statistical Analysis
Data are expressed as mean±SEM. Statistical evaluation was performed on the absolute values or on log transformed data with Student t test for unpaired data, 1-way ANOVA followed by a Bonferroni t test, or ANOVA for repeated measures where appropriate. Values of P<0.05 were considered statistically significant.
Results

Regulation of ACE Expression by Shear Stress
The application of shear stress to cultured human umbilical vein endothelial cells time-dependently decreased ACE mRNA expression ( Figure 1A ). The effect was relatively modest after 24 hours (28±8%) but increased with prolonged stimulation (up to 72 hours). A similar time-dependent decrease in ACE protein expression was detected with significant changes being recorded after 48 hours ( Figure 1B the endothelial NO synthase has previously been characterized as a shear stress-regulated gene, 19 the effectiveness of cell stimulation was assessed by monitoring endothelial NO synthase expression in the same cell lysates. NO has also previously been reported to negatively regulate ACE expression, 20 but despite the upregulation of the endothelial NO synthase in the samples analyzed, we were unable to detect any consequence of NO synthase inhibition on the shear stress-induced downregulation of ACE (data not shown). Shear stress also decreased ACE expression in human coronary artery endothelial cells (Online Figure IA) , indicating that the response is not restricted to cells of venous origin.
Effect of AMPK Activation/Downregulation on ACE Expression
AMPK is reported to regulate ACE expression in monocytes, 13 and because the kinase is activated in endothelial cells exposed to shear stress, 14, 21 we analyzed ACE protein expression in human endothelial cells after pharmacological AMPK activation. The AMP analog, 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside ( Figure 1C ), and the AMPK activators, metformin and thiopental, all decreased ACE mRNA (Online Figure IB ) and protein levels ( Figure 1D) ; albeit with slightly different time courses.
Next, we determined the consequences of AMPK downregulation on the shear stress-induced decrease of ACE expression in human endothelial cells. We found that downregulation of the AMPKα1 subunit slightly increased basal ACE expression but did not alter the sensitivity of the enzyme to shear stress ( Figure 1E ). Decreasing endothelial expression of the AMPKα2 subunit, on the contrary, significantly increased ACE expression under static conditions and abolished the response to shear stress.
To determine whether the negative regulatory effect of the AMPK observed in vitro is physiologically relevant, we assessed the expression of ACE in different arteries from AMPKα1 −/− or AMPKα2 −/− mice and their wild-type littermates (ie, AMPKα1 +/+ and AMPKα2
). Although ACE expression was similar in AMPKα1 +/+ and AMPKα1 −/− mice, the genetic deletion of AMPKα2 significantly increased ACE expression in the thoracic aorta ( 
Consequences of AMPKα Deletion on Vasodilator Responses to Bradykinin and ACE Inhibition
ACE not only generates angiotensin II but also degrades the vasodilator peptide bradykinin. Therefore, we assessed the consequences of AMPKα2 deletion on the bradykinininduced vasodilatation of an entire vascular bed, that is, the murine hindlimb, which includes areas of high as well as low flow. Consistent with our observation that ACE expression was elevated in femoral arteries of AMPKα2 −/− mice, the bradykinin-induced, endothelium-dependent vasodilatation of the hindlimb vasculature was significantly impaired ( Figure 3A ). The effects observed could be attributed to differences in ACE expression/activity rather than altered expression/sensitivity of the B 2 kinin receptor as the vasodilatation in both strains was comparable in the presence of an ACE inhibitor ( Figure  3B ). We found no difference in the acetylcholine-induced vasodilatation in AMPKα2 −/− and AMPKα2 +/+ animals (Online Figure IIIA) as well as no differences in the bradykinin-or acetylcholine-induced vasodilatation in AMPKα1 −/− and AMPKα1 +/+ animals (Online Figure IIIB and IIIC). Although bradykinin is an endothelium-dependent vasodilator, the AMPK may affect ACE expression in vascular smooth muscle cells and thus affect vascular responses to the kinin. Therefore, we reassessed bradykinin-induced vasodilatation in AMPKα2 ΔEC mice and found that the response to bradykinin was also attenuated ( Figure 3C ). Again the differences in bradykinin-induced vasodilatation between AMPKα2 +/+ and AMPKα2 ΔEC mice were abolished by ramiprilat ( Figure 3D ).
Regulation of Endothelial ACE Expression by miR-143 and miR-145
ACE is a target of the miR-143/145 gene cluster, and the protein is upregulated in vascular smooth muscle cells from 
miR-143/145
−/− mice. 11 Moreover, fluid shear stress increases miR-143/145 levels in commercially available human endothelial cells. 12 We found that freshly isolated and cultured (passage 1) human endothelial cells expressed low, but detectable, levels of miR-143 and miR-145, and that fluid shear stress increased the expression of both microRNAs (miRNAs) over 72 hours ( Figure 4A ). In cells cultured under static conditions, the overexpression of precursor (pre)-miR-143 or pre-miR-145 decreased endothelial ACE mRNA (Online Figure IVA) and protein levels ( Figure 4B ). Moreover, a mixture of specific antagomirs decreased miR-143/145 levels in human umbilical vein endothelial cells ( Figure 4C) , and prevented the shear stress-induced downregulation of ACE mRNA ( Figure 4D ) and protein ( Figure 4E ). AMPKα2 levels were not affected by the pre-miRs (data not shown). In human aortic endothelial cells, siRNA directed against AMPKα2 and antagomirs directed against miR-143/145 also increased basal ACE protein levels (Online Figure IVB) and prevented the decrease in ACE expression in response to shear stress (Online Figure IVC) .
Shear Stress, AMPKα2, and miR-143/145
To determine whether the shear stress-induced, AMPKdependent regulation of ACE could involve miR-143/145, we assessed the consequences of AMPKα2 downregulation on miRNA levels. Downregulation of the AMPKα2, but not the AMPKα1, subunit decreased the expression of miR-143 and miR-145 in cells maintained under static conditions (Online Figure IVD) and largely prevented the shear stress-induced increase in miR-143/145 levels ( Figure 5A ). Consistent with these in vitro findings, miR-143 and 145 levels were decreased in aortae from AMPKα2 −/− versus AMPKα2 +/+ mice ( Figure 5B ). Fluid shear stress was recently reported to increase the expression of miR-143/145 by a KLF2-dependent mechanism. 12 Although siRNA-based experiments previously revealed no link between KLF2 and shear stress-induced changes in ACE expression, 10 we investigated a possible link between KLF2 and AMPK activation. Although shear stress clearly increased KLF2 expression ( Figure 6A) , there was no effect of AMPK downregulation on the shear stress-induced increase in KLF2 mRNA ( Figure 6B ) or protein levels ( Figure 6C ). KLF2 was also not upstream of AMPK activation because the downregulation of KLF2 (Online Figure VA) was without effect on AMPKα2 expression ( Figure 6D ). Moreover, in primary human umbilical vein endothelial cells, KLF2 siRNA did not affect the shear stress-induced increase in either miR-143 or miR-145 ( Figure 6E) .
The involvement of an additional shear stress-sensitive transcription factor seemed unlikely as the primary (pri-) miR-143/145 transcripts were unaffected by shear stress over a 72-hour period ( Figure 7A and 7B) . The failure to detect primiR-143/145 was not a technical problem because primary transcripts increased in cells treated with transforming growth factor-β (Online Figure VB and VC) , which was previously classified as a transcriptional regulator of miR-143/145. 22 To address this issue more closely, we assessed the consequences of shear stress on the activity of the miR-143/145 promoter using endothelial cells isolated from miR-LacZ mice, in which the miR-143/145-coding region was replaced with a LacZ reporter. Although transforming growth factor-β increased galactosidase activity in these cells, there was no detectable effect of shear stress ( Figure 7C ). As a consequence of miR-143/145 deficiency, ACE was more highly expressed in endothelial cells from homozygous miR-LacZ mice than in cells from their heterozygous littermates (Online Figure VI) .
How can shear stress affect miR-143/145 levels independently of KLF2 and promoter activation? After being transcribed, the primary miRNAs are processed into precursor miRNAs (pre-miRs), of ≈70 nucleotides that are subsequently exported to the cytoplasm. 23 Interestingly, despite the lack of effect on pri-miR levels and miR-143/145 promoter activity, fluid shear stress increased pre-miR-and mature miR-143/145 levels in endothelial cells ( Figure 7A and 7B), indicating regulation by a post-translational mechanism. In agreement with these findings, AMPKα2 downregulation in cultured endothelial cells had no effect on pri-miR levels ( Figure 7D ), but decreased pre-miR-143/145 under static conditions ( Figure  7E ). Similarly, pre-miR-143 and -145 levels were reduced in endothelial cells isolated from lungs of AMPKα2 −/− mice ( Figure 7F ). AMPKα1 siRNA was without any effect on pri-or pre-miR levels. In heterozygous miR-LacZ mice, mature miR-143/145 levels were increased by shear stress ( Figure 7G ), and ACE expression was attenuated (Online Figure VI) .
AMPK, p53, and miR-143/145
Relatively little is known about the post-transcriptional regulation of miRNAs, 24 but the tumor suppressor p53 was found to interact with the Drosha-p68 processing complex to enhance the post-transcriptional processing of several miRNAs, including miR-143/145. 25 Given that p53 is a well-characterized AMPK substrate, 26 and was phosphorylated (on Ser15) by human recombinant AMPKα2 in vitro ( Figure 8A ), we determined whether or not the AMPK-dependent phosphorylation and activation of p53 were involved in the regulation of ACE expression by shear stress.
Shear stress induced the translocation of p53 to the detergentinsoluble fraction of endothelial cell lysates ( Figure 8B ), reflecting its activation. Moreover, the phosphorylation of p53 on Ser15 was increased (141±18% over basal levels) in response to shear stress, an effect that was prevented by the downregulation of the AMPKα2, but not the AMPKα1, subunit ( Figure 8C ). Similar effects were also observed in human aortic endothelial cells (Online Figure VIIA) . Although p53 activation is associated with apoptotic processes, endothelial cells exposed to shear stress were protected against the induction of apoptosis, 27 and we were unable to detect any increase in caspase 3 cleavage in endothelial cells exposed to shear stress (Online Figure  VIIB) . Pretreatment with siRNA against p53, which reduced p53 mRNA expression to 23±2% of its basal level ( Figure 8D ), decreased pre-and mature miR-143/145 levels, without affecting levels of the primary transcript (Online Figure VIIC) and increased ACE protein expression ( Figure 8E ). Moreover, p53 siRNA prevented the shear stress-induced downregulation of ACE mRNA (Online Figure VIID) and protein ( Figure 8F ).
To determine whether the AMPK-p53-miR-143/145-ACE pathway is of pathophysiological relevance, we studied AMPK activation, miRNA levels, and ACE expression in a mouse model of diabetes mellitus. Streptozotocin-induced diabetes mellitus in wild-type mice was associated with the increased phosphorylation of the AMPK substrates, p53 and acetyl-coenzyme A carboxylase ( Figure 8G) , and a significant reduction in ACE expression ( Figure 8H ). In the same animals, levels of mature miR-143/145 ( Figure 8I ) and premiR-143/145 ( Figure 8J ) increased, whereas pri-miR-143/145 levels were unaffected ( Figure 8J ).
Discussion
Increased ACE expression is generally associated with a higher risk of cardiovascular disease development and progression, because it contributes to the development of hypertension, myocardial infarction, stroke, and atherosclerosis as well as to the renal pathophysiology associated with several diseases including diabetes mellitus. ACE inhibitors are widely used clinically and effectively to lower blood pressure and promote the reverse remodeling of the vasculature, 28 but the molecular mechanisms that regulate ACE expression are unclear. The results of the present study indicate that endothelial ACE expression is downregulated in response to shear stress by a mechanism that involves activation of the AMPK, the subsequent phosphorylation and activation of p53, and the post-transcriptional upregulation of miR-143/145. Deletion experiments with siRNA revealed that the downregulation of ACE is dependent on the α2 catalytic subunit rather than AMPKα1. Indeed, AMPKα2-deficient mice demonstrated increased ACE expression in several vascular beds, coupled to an impaired vasodilator response to the ACE substrate, bradykinin.
The AMPK is a metabolite-sensing kinase that, when activated, initiates steps to conserve cellular energy. 29 Although there is a strong link between the activity of the AMPK and metabolic control in muscle cells, the activity of the kinase in endothelial cells can be regulated by stimuli that affect cellular ATP levels (eg, hypoxia), as well as by stimuli that activate upstream kinases. The latter include fluid shear stress, Ca 2+ -elevating agonists, and hormones, such as adiponectin. 29 At the outset of this study, circumstantial evidence suggested a link between fluid shear stress, the AMPK, and ACE expression as (1) ACE levels are decreased by shear stress, [8] [9] [10] (2) shear stress elicits activation of the AMPK, 14 (3) LKB1 (an AMPK kinase) was linked to ACE expression in the mouse intestine, 30 and (4) AMPK inhibition prevents the increase in ACE expression in macrophages induced by adipocyte-derived factors. 13 However, direct molecular links between the different events were missing. There are 2 AMPK catalytic subunits, and although the AMPKα1 has been the major focus of studies in the vasculature, 31 ,32 the α2 subunit is also expressed in endothelium and has been implicated in the regulation of endothelial cell signaling and function. 33 The AMPKα2 subunit also seems to be the isoform most closely linked to cardiovascular disease development, especially when accompanied by metabolic disturbances because the AMPKα2 determines whole body insulin sensitivity. 17 Our first step was to determine which of the α subunits contributed to the regulation of ACE expression and found that the downregulation of AMPKα2, but not AMPKα1, increased ACE expression in human endothelial cells and prevented its downregulation by shear stress in vitro. A similar upregulation of ACE was evident in a number of vessels in AMPKα2 −/− mice, findings that went hand in hand with the markedly attenuated vasodilator response to bradykinin in the hindlimb vascular bed. Bradykinin is an ACE substrate, and the fact that attenuated vasodilatation was observed in AMPKα2 −/− as well as in animals lacking the AMPKα2 specifically in endothelial cells (AMPKα2 ΔEC ), and was abolished in animals receiving an ACE inhibitor, underlined the importance of altered endothelial AMPK activity on vascular responsiveness.
How can the AMPKα2 regulate the expression of ACE? The AMPKα2 is translocated to the nucleus after activation 34 and is known to modulate the activity of several transcription factors and coactivators. 35 One transcription factor of particular interest was KLF2 because it is induced by shear stress, 36 and KLF2 overexpression was initially reported to decrease endothelial cell ACE expression. 10 However, the latter study also reported that siRNA directed against KLF2 failed to prevent the shear stressinduced downregulation of ACE RNA levels, indicating that the mechanisms must be distinct. We also found that the downregulation of KLF2 had no effect on the shear stress-induced downregulation of ACE and were unable to link KLF2 induction with AMPKα2. Given that miR-143/145 was found to regulate ACE expression in vascular smooth muscle cells, 11 we concentrated on establishing a link between AMPK-miR-143/145 and ACE in endothelial cells. We found that shear stress increased endothelial miR-143/145 levels and in turn strongly downregulated ACE expression, but only in cells expressing AMPKα2. The specificity of the response was demonstrated in experiments involving the overexpression of the appropriate pre-miR as well as by experiments using a mixture of antagomirs that abolished the shear stress-induced changes in ACE levels.
After transcription, primary miRNAs (pri-miRs) are processed into precursor miRNAs (pre-miRs) of ≈70 nucleotides that are subsequently exported to the cytoplasm where they are cleaved by Dicer to generate the mature 22 nucleotide miRNA. 23 Interestingly, we found that although shear stress increased the precursor and mature forms of miR-143/145, there was no detectable effect on primary miR-143/145 levels in endothelial cells. We were able to rule out a shear stress-induced increase in miR-143/145 transcription, because shear stress failed to affect miR-143/145 promoter activity in endothelial cells isolated from homozygous or heterozygous miR-143/145-deficient (miR-LacZ) mice. Consistently, primary miR-143/145 levels did not increase in response to shear stress in cells from heterozygous miR-LacZ mice, whereas precursor and mature forms of miR-143/145 did. These observations indicated that the effects of shear stress on miR-143/145 expression are mediated by a post-translational mechanism.
To establish how AMPK could modulate post-transcriptional processing of miR-143/145, we focused on p53, as it is a well-characterized AMPK substrate, 37 activated by shear stress, 38 and involved in the regulation of miRNA transcription and processing. 25 Indeed, p53 activation has been demonstrated to increase the levels of pre-miR-143/145 and mature miR-143/145, without affecting the primary miRNA transcripts. 25 Such findings were highly reminiscent of our observations in endothelial cells exposed to shear stress, and it was possible to demonstrate the involvement of p53 in the regulation of endothelial miR-143/145 levels by downregulating p53, which reduced precursor and mature miR-143/145 expression and prevented the shear stress-induced decrease in ACE expression. Downregulation of the AMPKα2 also decreased pre-miR, but not pri-miR, levels in cultured endothelial cells, leading us to conclude that the effects observed are related to the AMPKα2-dependent activation of p53. Although p53 is frequently associated with DNA damage, the shear stressinduced and AMPKα2-dependent phosphorylation of p53 was on Ser15, a phosphorylation site previously linked to cell survival. 39 Indeed, rather than promoting apoptosis, low levels of p53 activity have been linked with the induction of antiapoptotic and antioxidant genes as well as genes involved in DNA repair and the promotion of survival. 40 It is not entirely clear how p53 affects post-transcriptional miR levels, but it is likely to interfere with the Drosha processing step as coimmunoprecipitation demonstrated that p53 was associated with Drosha complex through its interaction with p68/p72. 25 The AMPKα2 is reported to protect against the development of atherosclerosis, 41 and alterations in AMPK activity have been linked with diabetes mellitus. 42 In agreement with other reports, [43] [44] [45] [46] we found that AMPK activity was increased in mice (evidenced by an increase in the phosphorylation of p53 and the acetyl-coenzyme A carboxylase) 10 weeks after the induction of diabetes mellitus with streptozotocin. These changes were paralleled by an increase in precursor and mature miR-143/145 levels, with no apparent change in the primary transcripts, and by a decrease in ACE expression. Although diabetes mellitus-associated metabolic stress activates the AMPK, 46 the situation is likely to be different in the later stages or more severe forms of diabetes mellitus, in which AMPK activity is thought to be impaired 47, 48 and associated with the accelerated development of cardiovascular disease. In such a state, the activation of the AMPK may help to prevent the vascular complications associated with the metabolic syndrome, 33, 49 for example, by modulation of the miRNA profile and the consequent reduction in ACE expression. So far, the spectrum of miRs that can be affected by changes in AMPKα2 activity is not known. However, the antidiabetic and AMPK-activating drug, metformin, alters the tumor suppressor miRNA let-7a and the transforming growth factor-β-induced oncomiR miR-181a in breast cancer epithelial cells. 50 Metformin also upregulates miR-26a, miR-192, and let-7c in human pancreatic cancer cells. 50 Although the role of p53 activation has not been addressed in the latter studies, it is striking that miR let-7a, miR-26a, and miR-192 are all regulated by p53 in different forms of cancer. 25 , 51, 52 Taken together, the results of this study suggest that the downregulation of ACE in endothelial cells exposed to arterial levels of shear stress could be attributed to the activation of the AMPK, the phosphorylation and activation of p53, and an alteration in miR processing that leads to an increase in miR-143/145 levels. The latter miRs were recently characterized as antiatherosclerotic because miR-145 levels are reduced in patients with coronary artery disease, 53 and targeting miR-145 exerts a pronounced effect on neointima formation inasmuch as the introduction of miR-145 into balloon-injured arteries inhibits neointimal growth. 54 It is tempting to speculate that this effect might also be related to altered ACE expression, because a small increase in ACE levels can markedly influence the magnitude of cuff-induced neointima thickening in mice. 55 The post-translational regulation of endothelial cell miRNA expression by a metabolically regulated kinase provides a potential link between metabolic conditions, such as diabetes mellitus, altered vascular homeostasis, and gene expression, and may help to account for the ability of metformin therapy to decrease cardiovascular events. 56, 57 
